Ikarian Capital, LLC
DALLAS, TX · CIK 1778253 · 13F filing filed 2023-08-14
SEC-registered investment adviser since 2020 · limited liability company
- Assets managed$698.0m
- Staff8 · 3 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $564.0m gross assets
- Form ADV · 2026-05-20SEC adviser record
- Legal entityIKARIAN CAPITAL, LLC (US)
- Kindhedge funds, futures
- Others nearbyDallas, TX
As an employer
- Offices in1 country
- Private fundshedge 1
$296.4m
reported value
+23.0% vs Q1 2023
81positions
54.1%in top 10
26 new
11 added
18 reduced
35 sold out
vs Q1 2023
Options: 24 call positions ($174.4m notional), 17 put positions ($170.0m notional) – listed below, not included above.
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ACELYRIN INC COM | $61.0m20.58% | New |
| CHINOOK THERAPEUTICS INC ADRO | $13.0m4.40% | Unchanged |
| APELLIS PHARMACEUTICALS INC APLS | $12.2m4.11% | Added +33.8k |
| MERCK & CO INC MRK | $11.5m3.89% | Unchanged |
| IDEAYA BIOSCIENCES INC IDYA | $11.5m3.89% | New |
| NUVALENT INC COM | $11.5m3.88% | New |
| DISC MEDICINE INC IRON | $10.7m3.60% | New |
| INSMED INC INSM | $10.2m3.45% | Unchanged |
| BIOHAVEN LTD BHVN | $10.2m3.45% | Added +25.1k |
| CRINETICS PHARMACEUTICALS IN CRNX | $8.6m2.89% | New |
| IMMUNOGEN INC IMGN | $8.4m2.85% | New |
| BRIDGEBIO PHARMA INC BBIO | $7.4m2.49% | Reduced -165.0k |
| VAXCYTE INC PCVX | $7.0m2.36% | Reduced -85.0k |
| MARINUS PHARMACEUTICALS INC MRNS | $6.6m2.24% | New |
| BIOMEA FUSION INC BMEA | $6.1m2.04% | Added +64.9k |
| ARCUS BIOSCIENCES INC RCUS | $5.7m1.92% | Added +50.0k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $5.6m1.89% | New |
| XENON PHARMACEUTICALS INC XENE | $5.2m1.76% | Reduced -25.0k |
| BICYCLE THERAPEUTICS PLC BCYC | $5.2m1.75% | Reduced -4.1k |
| ASTRIA THERAPEUTICS INC CATB | $4.8m1.63% | Reduced -290.0k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $4.6m1.56% | New |
| LYRA THERAPEUTICS INC LYRA | $4.0m1.36% | Added +634.9k |
| LONGBOARD PHARMACEUTICALS IN COM | $3.7m1.25% | New |
| VOYAGER THERAPEUTICS INC VYGR | $3.4m1.16% | New |
| ALLAKOS INC ALLKG | $3.4m1.14% | New |
| ACUMEN PHARMACEUTICALS INC ABOS | $3.2m1.06% | Added +400.0k |
| TERNS PHARMACEUTICALS INC COM | $2.8m0.93% | Reduced -405.9k |
| BLACK DIAMOND THERAPEUTICS I BDTX | $2.8m0.93% | New |
| DECIPHERA PHARMACEUTICALS IN DCPH | $2.5m0.83% | Unchanged |
| ESPERION THERAPEUTICS INC NE ESPR | $2.4m0.80% | Added +350.0k |
| ROIVANT SCIENCES LTD ROIV | $2.3m0.77% | Reduced -350.0k |
| ACLARIS THERAPEUTICS INC ACRS | $2.1m0.70% | Reduced -100.0k |
| KEZAR LIFE SCIENCES INC COM | $2.1m0.70% | Unchanged |
| BIOVIE INC CL A NEW | $1.9m0.65% | Added +100.0k |
| INTERCEPT PHARMACEUTICALS IN ICPT | $1.8m0.60% | Added +75.0k |
| ELEVATION ONCOLOGY INC COM | $1.7m0.59% | New |
| LEGEND BIOTECH CORP LEGN | $1.7m0.58% | New |
| MERUS N V MRUS | $1.7m0.56% | Reduced -145.5k |
| IMMUNIC INC COM | $1.6m0.55% | Unchanged |
| JASPER THERAPEUTICS INC COM | $1.5m0.52% | Reduced -1.2k |
| SCPHARMACEUTICALS INC SCPH | $1.5m0.52% | New |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $1.5m0.51% | Unchanged |
| BLUEBIRD BIO INC COM | $1.4m0.46% | Unchanged |
| MILESTONE PHARMACEUTICALS IN MIST | $1.3m0.44% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $1.3m0.43% | Unchanged |
| RENEO PHARMACEUTICALS INC COM | $1.0m0.34% | Unchanged |
| PROTAGONIST THERAPEUTICS INC PTGX | $966.7k0.33% | New |
| ARDELYX INC ARDX | $945.2k0.32% | Reduced -300.0k |
| TYRA BIOSCIENCES INC TYRA | $820.3k0.28% | Unchanged |
| TRACON PHARMACEUTICALS INC COM NEW | $804.8k0.27% | Unchanged |
| PROQR THRAPEUTICS N V PRQR | $765.7k0.26% | Unchanged |
| STOKE THERAPEUTICS INC STOK | $748.2k0.25% | New |
| COGENT BIOSCIENCES INC COGT | $743.1k0.25% | Unchanged |
| KARYOPHARM THERAPEUTICS INC COM | $716.0k0.24% | Added +100.0k |
| X4 PHARMACEUTICALS INC COM | $677.3k0.23% | Unchanged |
| AUTOLUS THERAPEUTICS PLC AUTL | $619.0k0.21% | Unchanged |
| FIBROGEN INC COM | $616.7k0.21% | New |
| IMMATICS N.V IMTX | $565.8k0.19% | Reduced -130.5k |
| REATA PHARMACEUTICALS INC RETA | $557.9k0.19% | Reduced -75.1k |
| HOOKIPA PHARMA INC COM | $528.0k0.18% | New |
| OCULAR THERAPEUTIX INC OCUL | $516.0k0.17% | Reduced -100.0k |
| PROTARA THERAPEUTICS INC TARA | $450.9k0.15% | Unchanged |
| KODIAK SCIENCES INC KOD | $431.4k0.15% | Reduced -100.0k |
| BRAINSTORM CELL THERAPEUTICS COM NEW | $391.3k0.13% | Unchanged |
| ANEBULO PHARMACEUTICALS INC ANEB | $340.5k0.11% | Unchanged |
| ELEDON PHARMACEUTICALS INC ELDN | $303.9k0.10% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $300.2k0.10% | New |
| CHEMOMAB THERAPEUTICS LTD SPONSORED ADS | $279.5k0.09% | Reduced -23.3k |
| POINT BIOPHARMA GLOBAL INC COM | $260.8k0.09% | Reduced -110.8k |
| CONNECT BIOPHARMA HLDGS LTD ADS | $243.6k0.08% | Unchanged |
| VERONA PHARMA PLC VRNA | $219.2k0.07% | Added +85.0k |
| ASCENDIS PHARMA A/S SPONSORED ADR | $186.5k0.06% | New |
| MERSANA THERAPEUTICS INC COM | $164.5k0.06% | New |
| RELMADA THERAPEUTICS INC RLMD | $161.1k0.05% | Unchanged |
| SYNLOGIC INC COM | $131.9k0.04% | Unchanged |
| AVROBIO INC COM | $127.5k0.04% | New |
| FOGHORN THERAPEUTICS INC FHTX | $105.6k0.04% | New |
| FINCH THERAPEUTICS GROUP INC COM NEW | $67.5k0.02% | New |
| ASLAN PHARMACEUTICALS LTD SPON ADS NEW | $29.8k0.01% | Unchanged |
| MADRIGAL PHARMACEUTICALS INC MDGL | $17.3k0.01% | Unchanged |
| ERYTECH PHARMA SPONSORED ADR | $2.3k0.00% | Reduced -245.4k |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| PROMETHEUS BIOSCIENCES INC | $13.5m125.9k shares |
| IMMUNOVANT INC IMVT | $12.0m774.4k shares |
| BELLUS HEALTH INC NEW BLU | $6.4m885.3k shares |
| IVERIC BIO INC OPHT | $5.2m213.5k shares |
| BIOMARIN PHARMACEUTICAL INC BMRN | $4.9m50.0k shares |
| AEROVATE THERAPEUTICS INC | $3.9m195.1k shares |
| CELLDEX THERAPEUTICS INC NEW CLDX | $3.8m106.1k shares |
| SELECT SECTOR SPDR TR XLV | $3.6m27.5k shares |
| ALTIMMUNE INC ALT | $2.9m677.3k shares |
| BIOXCEL THERAPEUTICS INC | $2.5m133.0k shares |
| VENTYX BIOSCIENCES INC VTYX | $2.2m65.0k shares |
| CYTOKINETICS INC CYTK | $2.0m55.7k shares |
| AKERO THERAPEUTICS INC AKRO | $1.9m50.0k shares |
| MACROGENICS INC MGNX | $1.8m250.0k shares |
| MORPHIC HLDG INC MORF | $1.7m45.9k shares |
| ARK ETF TR ARKG | $1.4m46.5k shares |
| MIRATI THERAPEUTICS INC MRTX | $1.2m33.1k shares |
| SAREPTA THERAPEUTICS INC SRPT | $1.1m8.3k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $1.1m60.0k shares |
| DELCATH SYS INC DCTH | $1.1m360.6k shares |
| INVENTIVA SA IVA | $999.2k292.6k shares |
| ACHIEVE LIFE SCIENCES INC ACHV | $989.5k174.7k shares |
| SAGE THERAPEUTICS INC SAGE | $747.1k17.8k shares |
| VIKING THERAPEUTICS INC VKTX | $718.5k43.2k shares |
| AMYLYX PHARMACEUTICALS INC AMLX | $293.4k10.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ARGENX SE ARGX · Put | $51.5m132.1k shares | New |
| BRIDGEBIO PHARMA INC BBIO · Call | $21.2m1.2m shares | Added |
| BIOMEA FUSION INC BMEA · Call | $20.6m936.8k shares | Added |
| TG THERAPEUTICS INC TGTX · Call | $20.5m826.1k shares | New |
| TG THERAPEUTICS INC TGTX · Put | $20.5m826.1k shares | New |
| ASTRAZENECA PLC Call | $17.9m250.0k shares | New |
| ARGENX SE ARGX · Call | $14.8m38.0k shares | New |
| SAREPTA THERAPEUTICS INC SRPT · Put | $14.0m122.1k shares | Reduced |
| VENTYX BIOSCIENCES INC VTYX · Put | $12.3m374.1k shares | New |
| APELLIS PHARMACEUTICALS INC APLS · Put | $12.1m133.0k shares | New |
| CRISPR THERAPEUTICS AG CRSP · Put | $11.2m200.0k shares | New |
| CRISPR THERAPEUTICS AG CRSP · Call | $11.2m200.0k shares | New |
| REATA PHARMACEUTICALS INC RETA · Call | $11.2m110.0k shares | Added |
| BIOMARIN PHARMACEUTICAL INC BMRN · Put | $8.7m100.0k shares | New |
| ACLARIS THERAPEUTICS INC ACRS · Put | $8.3m796.3k shares | Added |
| REPLIMUNE GROUP INC REPL · Put | $8.1m348.2k shares | New |
| IMMUNOGEN INC IMGN · Call | $6.6m350.0k shares | Added |
| BIOMEA FUSION INC BMEA · Put | $6.3m286.7k shares | Added |
| IMMUNOVANT INC IMVT · Call | $6.2m326.2k shares | Added |
| PROTAGONIST THERAPEUTICS INC PTGX · Put | $5.8m211.4k shares | Unchanged |
| PROTAGONIST THERAPEUTICS INC PTGX · Call | $5.5m200.0k shares | Reduced |
| BIOHAVEN LTD BHVN · Call | $5.4m225.0k shares | Added |
| REPLIMUNE GROUP INC REPL · Call | $5.3m228.3k shares | New |
| LEGEND BIOTECH CORP LEGN · Call | $4.7m68.8k shares | New |
| INSMED INC INSM · Call | $4.2m200.0k shares | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| NEXTCURE INC NXTC · 13G · filed 2026-08-14 | 10.0%≈ $804.3k |
| CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 | 9.9%≈ $704.0k |
| TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 | 9.5%≈ $1.3m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 | 9.0%≈ $1.7m |
| PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 | 7.7%≈ $7.3m |
| CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 | 7.3% |
| CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 | 6.9% |
| LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 | 6.3% |